Trade of the Day: Gilead Sciences, Inc. (GILD) Stock Looks Like a Bargain

Advertisement

Gilead Sciences, Inc. (NASDAQ:GILD) — On Nov. 1, Standard & Poor’s Capital IQ lowered their target by $20 to $105 on Gilead; however, they kept their strongest buy rating, a five-star “buy” on the stock with a “next 12-months EPS estimate of $11.36.”

Sales and earnings fell for the third quarter, and they lowered their 2017 earnings estimate to $11.44, down from $11.62 in 2016. But HIV sales were strong, up 20.7%, and S&P views the stock, now trading at 6.6X the next 12-month EPS as a strong purchase.

They also forecast a large cash flow, positive capital deployment and market leadership in HCV (hepatitis C) and HIV treatments. They note a “solid pipeline” of future treatments for viral, bacterial and fungal infections, cardiovascular conditions and cancer. But its strongest recommendation of “five-stars” is based on the very low price-to-earnings ratio of 9.25X, which is below peers by a significant margin. GILD pays an annualized dividend of $1.88 for a dividend yield of 2.5%.

Technically, GILD appears to be in the process of building a base. It broke through its bearish resistance line early this month on a high-volume gap from a bullish “W” formation, briefly penetrating its 50-day moving average at $76.50.

The remainder of November was spent consolidating under the 50-day MA, and last week it made several attempts to attack it. Until GILD breaks above the 50-day moving average and successfully holds above $80, I consider it in a downtrend recovery mode. However, fundamentals appear to be improving, and for those who search for a bargain, I know of no better trade or investment than Gilead Sciences.

Buy GILD at $75 with a target of $85-plus. A stop-loss at $71 is suggested in the event that the stock resumes a downtrend.

GILD Buy $75 Tgt $85
Click to Enlarge

Russell 2000


Article printed from InvestorPlace Media, https://investorplace.com/2016/11/gilead-sciences-inc-gild-stock-bargain/.

©2024 InvestorPlace Media, LLC